This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...

Please provide your email address to receive an email when new articles are posted on . Stereotactic radiosurgery conferred equivalent OS as whole-brain radiation but with less cognitive decline in ...

In the field of stereotactic radiosurgery of the brain, the fixation pins that keep a head frame perfectly stable during treatment perform differently. That was the surprising discovery made by Ronald ...

Of the study participants, 182 received stereotactic radiosurgery, while 79 did not. The patients who underwent radiosurgery using the Gamma Knife system showed consistently better tumor control over ...

Trans-sphenoidal neurosurgery is the gold standard treatment for pituitary adenomas, but it can be contraindicated or ineffective. Stereotactic radiosurgery is a procedure aimed at controlling hormone ...

Stereotactic radiosurgery is performed using Cyberknife, a robotic radiosurgery system which delivers targeted doses of radiation with sub-millimeter accuracy while minimizing damage to surrounding ...

Brain metastases are a challenge for the oncologist, with 20–40% of cancer patients developing intracranial metastases during the course of their illness. The incidence of brain metastases is ...

November 6, 2009 — Results from a long-term cohort study in patients with medically refractory Parkinson's disease (PD) and essential tremor (ET) suggest that stereotactic radiosurgery (SRS) provides ...

ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that the European ...

Stereotactic radiosurgery appears to be feasible, safe, and effective for patients with 15 or more brain metastases and may be a viable alternative to whole brain radiation therapy (WBRT) alone in ...

Brain metastases are the most common intracranial malignancy. Incidence of brain metastases has risen as systemic therapies have improved and patients with metastatic disease live longer. Whole-brain ...